Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease
批准号:
9265401
负责人:
ELAINE R. PESKIND
金额:
$33.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2021-04-30
中文摘要
描述(由申请人提供):我们正在申请阿尔茨海默病培训计划(ADTP)“阿尔茨海默病的神经行为、神经病理学和风险因素”的资助。“我们的项目专注于阿尔茨海默病(AD)和相关痴呆症的转化研究。我们的研究培训计划的目标是为基础科学,临床和翻译研究人员提供跨学科的培训,使他们能够推进有关AD和相关疾病的病因,病理生理学和治疗的临床假设。我们的培训项目是华盛顿大学唯一的正式项目,专注于培训研究人员在AD和相关神经退行性痴呆症中进行基础,临床和转化研究。 我们的计划得到了华盛顿大学和退伍军人事务部普吉特海湾医疗保健系统丰富和互动的研究环境的支持,在那里,大量的教师在AD和相关痴呆症的范围内进行研究。该计划正在为5名博士后培训生申请培训职位。对于博士后学员,我们的目标是有~40%的临床(医学博士,医学博士/博士,或临床心理学博士)和~60%的研究(博士)博士后研究员。进入MD候选人预计已完成住院医师,通常在精神病学,神经病学,神经病理学,放射学,内科或老年医学。博士后博士候选人来自广泛的学科,包括临床心理学,神经心理学,生物化学,遗传学,神经生物学和药理学。基础科学培训生通常在研究生培训的第一年加入该计划,通常持续三年。医学博士和临床博士研究员预计将继续两年,并将强烈鼓励继续第三年。我们还要求4个博士前候选人的培训职位。博士前学员将从以下UW博士课程招募:基因组科学,疾病的分子基础,分子和细胞生物学,神经生物学和行为学以及药理学,并将在研究生培训的第二年或第三年加入ADTP计划。将作出特别征聘努力,将服务不足的少数族裔学员包括在内。
英文摘要
DESCRIPTION (provided by applicant): We are applying for funding of our Alzheimer's disease Training Program (ADTP), "Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease." Our program focuses on translational research in Alzheimer's disease (AD) and related dementias. The objective of our research training program is to provide interdisciplinary training for basic science, clinical, and translational researchers so that they ill be able to advance clinical hypotheses about the etiology, pathophysiology, and treatment of AD and related disorders. Our training program is the only formal program at the University of Washington focused on training investigators to carry out basic, clinical, and translational research in AD and related neurodegenerative dementing disorders. Our program is supported by the rich and interactive research environment of the University of Washington and Veterans Affairs Puget Sound Health Care System, where a critical mass of faculty conduct research across the spectrum of AD and related dementias. The program is requesting training positions for 5 postdoctoral trainees. For postdoctoral trainees our goal is to have ~40% clinical (MD, MD/PhD, or PhD in Clinical Psychology) and ~60% research (PhD) postdoctoral fellows. Incoming MD candidates are expected to have completed a residency, usually in psychiatry, neurology, neuropathology, radiology, internal medicine, or geriatric medicine. Postdoctoral PhD candidates from come a broad range of disciplines, including clinical psychology, neuropsychology, biochemistry, genetics, neurobiology, and pharmacology. Basic science trainees typically join the program during their 1st year of postgraduate training and usually remain for three years. MD and clinician PhD fellows are expected to remain for a two year period, and will be strongly encouraged to remain for a third. We are also requesting training positions for 4 predoctoral candidates. Predoctoral trainees will be recruited from the following UW PhD programs: Genome Sciences, Molecular Basis of Disease, Molecular and Cellular Biology, Neurobiology and Behavior, and Pharmacology, and will join the ADTP program in their 2nd or 3rd year of graduate training. Special recruitment efforts will be made to include underserved minority trainees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the Role of Post-TBI Sleep Disruption in the Development of CTE and Alzheimer's Disease-Related Neuropathology
-
批准号:10523939
-
项目类别:
-
资助金额:$385.99万
-
财政年份:2022
-
负责人:ELAINE R. PESKIND
-
依托单位:
Mild TBI and Biomarkers of Neurodegeneration
-
批准号:10490311
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:ELAINE R. PESKIND
-
依托单位:
Mild TBI and Biomarkers of Neurodegeneration
-
批准号:10269890
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:ELAINE R. PESKIND
-
依托单位:
Mild TBI and Biomarkers of Neurodegeneration
-
批准号:8864865
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:ELAINE R. PESKIND
-
依托单位:
Multimodal Biological Assessment of Gulf War Illness
-
批准号:9278098
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ELAINE R. PESKIND
-
依托单位:
Multimodal Biological Assessment of Gulf War Illness
-
批准号:8967215
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ELAINE R. PESKIND
-
依托单位:
Multimodal Biological Assessment of Gulf War Illness
-
批准号:8660563
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:ELAINE R. PESKIND
-
依托单位:
Simvastatin: Proof-of-Concept for Prevention of Neurodegeneration in Mild TBI
-
批准号:8485152
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ELAINE R. PESKIND
-
依托单位:
Simvastatin: Proof-of-Concept for Prevention of Neurodegeneration in Mild TBI
-
批准号:8990876
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:ELAINE R. PESKIND
-
依托单位:
Mild TBI and Biomarkers of Neurodegeneration
-
批准号:8256521
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ELAINE R. PESKIND
-
依托单位:
Mild TBI and Biomarkers of Neurodegeneration
-
批准号:8928103
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ELAINE R. PESKIND
-
依托单位:
Mild TBI and Biomarkers of Neurodegeneration
-
批准号:8088503
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ELAINE R. PESKIND
-
依托单位:
Mild TBI and Biomarkers of Neurodegeneration
-
批准号:8838166
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ELAINE R. PESKIND
-
依托单位:
Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
-
批准号:7910425
-
项目类别:
-
资助金额:$49.35万
-
财政年份:2009
-
负责人:ELAINE R. PESKIND
-
依托单位:
Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
-
批准号:7736328
-
项目类别:
-
资助金额:$49.47万
-
财政年份:2009
-
负责人:ELAINE R. PESKIND
-
依托单位:
Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
-
批准号:8111821
-
项目类别:
-
资助金额:$47.68万
-
财政年份:2009
-
负责人:ELAINE R. PESKIND
-
依托单位:
CORE--CLINICAL
-
批准号:6932654
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2005
-
负责人:ELAINE R. PESKIND
-
依托单位:
CORE--CLINICAL
-
批准号:6455077
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2001
-
负责人:ELAINE R. PESKIND
-
依托单位:
CORE--CLINICAL
-
批准号:6359533
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2000
-
负责人:ELAINE R. PESKIND
-
依托单位:
ALZHEIMER'S IN LONG TERM PROPRANOLOL FOR AGITATION
-
批准号:6372533
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2000
-
负责人:ELAINE R. PESKIND
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: